Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $23.3000 (4.34%) ($21.6100 - $23.4000) on Wed. May. 29, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.36% (three month average) | RSI | 19 | Latest Price | $23.3000(4.34%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA declines -0.9% a day on average for past five trading days. | Weekly Trend | ATRA declines -7.9% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(57%) ARKG(49%) IBB(49%) IWO(48%) ARKK(47%) | Factors Impacting ATRA price | ATRA will decline at least -2.18% in a week (0% probabilities). VXX(-34%) TLT(-13%) VIXM(-10%) UNG(-6%) IFRA(-5%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.18% (StdDev 4.36%) | Hourly BBV | 0 () | Intraday Trend | 5.4% | | | |
|
1 - 5 Day Possible Target | $-7.58(-132.53%) | Resistance Level | $26.93 | 5 Day Moving Average | $23.1(0.87%) | 10 Day Moving Average | $23.6(-1.27%) | 20 Day Moving Average | $26.93(-13.48%) | To recent high | -43.2% | To recent low | 4.3% | Market Cap | $1.731b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |